Pancreatic cancer is one of the most dangerous and difficult cancers to treat. Doctors often struggle to detect it early because the disease usually causes few symptoms in the beginning. By the time ...

The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job ...

“Start low, go slow.” Geriatric pharmacology texts and recent systematic reviews (e.g., on dosing of oncology drugs) warn ...

The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.

March 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Bristol Myers Squibb's combination treatment ...